Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Dacogen gains approval in the E.U. for acute myeloid leukemia

Oct. 2, 2012

Daiichi Sankyo divulges new Mdm2/p53 inhibitors

Oct. 2, 2012

Merck KGaA discloses novel agents for cancer

Oct. 2, 2012

Phase III trial of OncoGenex' lead candidate commences in advanced NSCLC

Oct. 1, 2012

Ariad completes rolling NDA submission for ponatinib

Oct. 1, 2012

Phase I data on veliparib in patients with brain metastases reported

Oct. 1, 2012

Research at the University of Pennsylvania yields new cancer biotherapeutics

Oct. 1, 2012

FDA approves Bayer's Stivarga for treatment of metastatic colorectal cancer

Sep. 28, 2012

Bristol-Myers Squibb files application in Japan for Taxol for germ cell tumors

Sep. 28, 2012

Array BioPharma and Genentech report novel ERK inhibitors

Sep. 28, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...